Table 1.

The effect of TNF- on hematopoiesis is dependent on GM-CSF

Culture Additions CFU-GM per 3 × 105 Splenocytes + 2 × 10314M1.4
Uninfected 14M1.4 Infected 14M1.4
1. 60 μg/mL HIgG  24.2 ± 1.2  57.7 ± 3.8  
2.  30 μg/mL α-GM-CSF + 30 μg/ml HIgG  10.3 ± 1.5* 18.7 ± 1.8* 
3.  30 μg/mL HIgG + 30 μg/mL α-TNFα  27.0 ± 1.5  42.3 ± 2.0* 
4.  30 μg/mL α-GM-CSF + 30 μg/mL α-TNFα  10.3 ± 1.2 14.3 ± 3.2 
Culture Additions CFU-GM per 3 × 105 Splenocytes + 2 × 10314M1.4
Uninfected 14M1.4 Infected 14M1.4
1. 60 μg/mL HIgG  24.2 ± 1.2  57.7 ± 3.8  
2.  30 μg/mL α-GM-CSF + 30 μg/ml HIgG  10.3 ± 1.5* 18.7 ± 1.8* 
3.  30 μg/mL HIgG + 30 μg/mL α-TNFα  27.0 ± 1.5  42.3 ± 2.0* 
4.  30 μg/mL α-GM-CSF + 30 μg/mL α-TNFα  10.3 ± 1.2 14.3 ± 3.2 

14M1.4 cells were untreated or infected with amastigotes at a ratio of 25:1 (amastigotes/cells). 14M1.4 cells were preincubated with control HIgG, anti-GM-CSF mAb, or anti-TNF-α mAb for 30 minutes before addition of spleen cells in methylcellulose. After 7 days, mature CFU-GM colonies were counted. Data represents the mean ± SEM for triplicate wells.

*

P < 0.05 compared to HIgG control (row 1).

P < 0.05 compared to HIgG (row 1), but not significant compared to anti-GM-CSF (row 2).